Occudo Quantitative Strategies’s Lifestance Health LFST Stock Holding History

Occudo Quantitative Strategies’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$576K	Sell	53,795 -101,113	-65%	-$781K	0.03%	472
2026 Q1	$1.17M	Buy	+154,908	New	+$1.08M	0.06%	361
2025 Q3	–	Sell	-50,957	Closed	-$263K	–	777
2025 Q2	$263K	Sell	50,957 -21,046	-29%	-$126K	0.03%	494
2025 Q1	$482K	Buy	+72,003	New	+$547K	0.06%	369
2024 Q2	–	Sell	-13,713	Closed	-$84.6K	–	879
2024 Q1	$84.6K	Sell	13,713 -62,559	-82%	-$421K	0.01%	667
2023 Q4	$597K	Sell	76,272 -34,359	-31%	-$221K	0.08%	342
2023 Q3	$760K	Buy	110,631 +22,678	+26%	+$184K	0.1%	361
2023 Q2	$803K	Buy	+87,953	New	+$731K	0.08%	399

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Occudo Quantitative Strategies's LFST Position: Q2 2026 in Review

Occudo Quantitative Strategies reduced its Lifestance Health (LFST) stake by 65% in Q2 2026, selling an estimated $781K and leaving 53,795 shares worth $576K. The position accounts for 0.03% of the portfolio, ranked #472.

Occudo Quantitative Strategies first reported a position in LFST in Q2 2023 and has held it in 8 quarters since. The position peaked at $1.17M in Q1 2026. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

Occudo Quantitative Strategies held 53,795 shares of Lifestance Health worth $576K as of Q2 2026.
Occudo Quantitative Strategies sold 101,113 Lifestance Health shares in Q2 2026, an estimated $781K.
Lifestance Health made up 0.03% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #472 holding.
Occudo Quantitative Strategies first reported a position in Lifestance Health in Q2 2023 and has held it in 8 quarters since.
Occudo Quantitative Strategies's Lifestance Health position peaked at $1.17M in Q1 2026.
287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.